Rare diseases
Investigational molecules
Locations
Study of Weekly Oral GS-1720 and GS-4182 for Untreated HIV-1 Patients
RomaniaStudy Comparing Elacestrant and Standard Endocrine Therapy for Patients with Early Breast Cancer at High Risk of Recurrence
RomaniaStudy of INBRX-106 and Pembrolizumab for First-Line Treatment in Patients with Recurrent or Metastatic Head and Neck Cancer
RomaniaStudy of Quizartinib with Chemotherapy for Adults with Newly Diagnosed FLT3-ITD Negative Acute Myeloid Leukemia
RomaniaComparison of two doses of cabozantinib (60 mg vs 140 mg) in patients with progressive metastatic medullary thyroid cancer
RomaniaStudy Comparing Effects and Safety of CT-P51 and Pembrolizumab with Drug Combination in Patients with Untreated Metastatic Non-Small Cell Lung Cancer
RomaniaLong-term safety and effectiveness study of pozelimab and cemdisiran combination treatment in adults with paroxysmal nocturnal hemoglobinuria (PNH)
RomaniaStudy on the Safety and Effectiveness of Pozelimab and Cemdisiran for Adults with Paroxysmal Nocturnal Hemoglobinuria Not Recently Treated with Complement Inhibitors
RomaniaStudy Comparing ABP 206 and Nivolumab for Patients with Unresectable or Metastatic Melanoma
RomaniaStudy on the Effects of Ianalumab with Standard Therapy for Patients with Active Lupus Nephritis
RomaniaStudy of Subcutaneous Nivolumab for Patients with Previously Treated Advanced or Metastatic Clear Cell Kidney Cancer
RomaniaStudy of Abemaciclib and Temozolomide for Children and Young Adults with Newly Diagnosed High-Grade Glioma After Radiotherapy
RomaniaTell us about your condition – we search every trial in Europe and connect you with the right site.
